Enovis (ENOV) Cash & Current Investments (2010 - 2026)
Enovis' (ENOV) quarterly Cash & Current Investments came in at $33.1 million in Q2 2026, down 13.86% year-on-year from $38.5 million in Q2 2025, and down 8.96% on a QoQ basis from $36.4 million in Q4 2025.
Enovis (ENOV) Cash & Current Investments (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Cash & Current Investments data on file, last reported at $33.1 million in Q2 2026.
- On a quarterly basis, Cash & Current Investments fell 13.86% year-over-year to $33.1 million in Q2 2026; TTM through Apr 2026 was $33.1 million, a 13.86% decrease from a year earlier, with the FY2025 full-year figure at $36.4 million, down 24.45% from the prior year.
- Cash & Current Investments for Q2 2026 stood at $33.1 million, down from $36.4 million in the prior quarter.
- Over the last five years, Cash & Current Investments for ENOV reached as high as $661.5 million in Q2 2022 and fell as low as $21.9 million in Q1 2023.
- Historically, Cash & Current Investments has averaged $105.5 million across 5 years, with a median of $36.2 million in 2023.
- Across the five-year window, Cash & Current Investments soared 475.64% in 2022 and sank 96.69% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $24.3 million in 2022, then soared by 48.96% to $36.2 million in 2023, then soared by 33.09% to $48.2 million in 2024, then slipped by 24.45% to $36.4 million in 2025, then fell by 8.96% to $33.1 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $33.1 million in Q2 2026, $36.4 million in Q4 2025, and $33.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Enovis | 1.61 Bn | 1.58 Bn | 365.49 Mn | 33.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 33.13 Mn |
| Dec 31, 2025 | 36.39 Mn |
| Oct 3, 2025 | 33.62 Mn |
| Jul 4, 2025 | 44.07 Mn |
| Apr 4, 2025 | 38.46 Mn |
| Dec 31, 2024 | 48.17 Mn |
| Sep 27, 2024 | 35.43 Mn |
| Jun 28, 2024 | 35.00 Mn |
| Mar 29, 2024 | 66.27 Mn |
| Dec 31, 2023 | 36.19 Mn |
| Sep 29, 2023 | 32.13 Mn |
| Jun 30, 2023 | 32.49 Mn |
| Mar 31, 2023 | 21.90 Mn |
| Dec 31, 2022 | 24.30 Mn |
| Sep 30, 2022 | 255.23 Mn |
| Jul 1, 2022 | 358.68 Mn |
| Apr 1, 2022 | 661.50 Mn |
| Dec 31, 2021 | 680.25 Mn |
| Oct 1, 2021 | 177.48 Mn |
| Jul 2, 2021 | 62.31 Mn |